Replies to post #323144 on Anavex Life Sciences Corp (AVXL)

[La Flaca]

I’m in a similar situation with number of shares and entry point. I had a similar strategy but rethinking given consistency of results across 3 indications. If Excellence and AVATAR results are good to great, which is what I assume moves the sp to $50, I’m not selling. I’ll ride it out until just before ALZ results next year. I think that the sp will rise even more with expectations of good to great results, especially with imminent Rett approval. At that point, I may sell some but not sure about tranches.